1056876-37-9

Basic information

• Product Name: 4-{[4-(tert-butoxycarbonyl)cyclohexyl]amino}-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid
• Synonyms: 4-{[4-(tert-butoxycarbonyl)cyclohexyl]amino}-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid
• CAS NO: 1056876-37-9
• Molecular Weight: 388.467
• Mol File: 1056876-37-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-{[4-(tert-butoxycarbonyl)cyclohexyl]amino}-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{[4-(tert-butoxycarbonyl)cyclohexyl]amino}-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid(1056876-37-9)
• EPA Substance Registry System: 4-{[4-(tert-butoxycarbonyl)cyclohexyl]amino}-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid(1056876-37-9)

Safety Data

• Hazardous Substances Data: 1056876-37-9(Hazardous Substances Data)

Upstream product

• 59060-16-1 4-chloro-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid 
• 124830-45-1 tert-butyl 4-aminocyclohexanecarboxylate 

Relevant articles and documents

PYRAZOLO [3, 4-B] PYRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS

The present invention relates to phosphodiesterase (PDE) type 4, phosphodiesterase (PDE) type 7 and dual PDE type 4 /PDE type 7 inhibitors. Compounds disclosed hereinf having the structure of Formula 1: can be useful in the treatment, prevention, inhibiti